drugset / Trial / NCT01846624

Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT01846624

Phase 2 Terminated 13 enrolled David Iberri
NaSingle-groupOpen-labelTreatment

Summary

This phase 2 study evaluates the sequential combination of decitabine then midostaurin for the treatment of newly-diagnosed acute myeloid leukemia (AML) in older patients.

Timeline

Start
2013-06
Primary completion
2016-07-22
Completion
2016-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Decitabine Small molecule Intravenous
Subject Midostaurin Small molecule Oral